B
Bashi Ratterree
Researcher at University of Maryland Marlene and Stewart Greenebaum Cancer Center
Publications - 7
Citations - 434
Bashi Ratterree is an academic researcher from University of Maryland Marlene and Stewart Greenebaum Cancer Center. The author has contributed to research in topics: Transplantation & Adoptive cell transfer. The author has an hindex of 5, co-authored 7 publications receiving 417 citations. Previous affiliations of Bashi Ratterree include University of Maryland, Baltimore.
Papers
More filters
Journal ArticleDOI
Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer
Aaron P. Rapoport,Edward A. Stadtmauer,Nicole A. Aqui,Ashraf Badros,Julio Cotte,Lisa Chrisley,Elizabeth Veloso,Zhaohui Zheng,Sandra Westphal,Rebecca Mair,Nina Chi,Bashi Ratterree,Mary Francis Pochran,Sabrina Natt,Joanne Hinkle,C Sickles,Ambika Sohal,Kathleen Ruehle,Christian Lynch,Lei Zhang,David L. Porter,Selina M. Luger,Chuanfa Guo,Hong-Bin Fang,William C. Blackwelder,Kim Hankey,Dean L. Mann,Robert R. Edelman,Carl E. Frasch,Bruce L. Levine,Alan S. Cross,Carl H. June +31 more
TL;DR: Combination immunotherapy consisting of a single early post-transplant infusion of in vivo vaccine-primed and ex vivo costimulated autologous T cells followed by post-Transplant booster immunizations improved the severe immunodeficiency associated with high-dose chemotherapy and led to the induction of clinically relevant immunity in adults within a month after transplantation.
Journal ArticleDOI
Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells.
Aaron P. Rapoport,Bruce L. Levine,A. Badros,Barry Meisenberg,Kathleen Ruehle,A Nandi,S Rollins,Sabrina Natt,Bashi Ratterree,Sandra Westphal,Dean L. Mann,Carl H. June +11 more
TL;DR: Autotransplantation followed by costimulated autologous T cells is feasible for patients with chronic phase CML, who lack allogeneic donors and can be associated with molecular remissions.
Chronic myeloid leukemia Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells
AP Rapoport,Bruce L. Levine,A. Badros,Barry Meisenberg,Kathleen Ruehle,A Nandi,S Rollins,Sabrina Natt,Bashi Ratterree,Sandra Westphal,Dean L. Mann +10 more
TL;DR: In this paper, four patients with chronic myelogenous leukemia (CML) that was refractory to interferon alpha or imatinib mesylate (two patients), and who lacked donors for allogeneic stem cell transplantation, received autotransplants followed by infusions of ex vivo costimulated autologous T cells.
Journal ArticleDOI
Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma.
Aaron P. Rapoport,Chuanfa Guo,Ashraf Badros,R Hakimian,Gorgun Akpek,E Kiggundu,Barry Meisenberg,H Mannuel,Naoko Takebe,Robert G. Fenton,Javier Bolaños-Meade,Meyer R. Heyman,Ivana Gojo,Kathleen Ruehle,Sabrina Natt,Bashi Ratterree,T Withers,C Sarkodee-Adoo,G L Phillips,G. Tricot +19 more
TL;DR: The role of consolidation chemotherapy (CC) after auto-PBSCT in 37 patients with relapsed or refractory HD was prospectively studied, finding that post-transplant CC is feasible and well tolerated.
Journal ArticleDOI
Phase II Trial of Oblimersen Sodium (G3139), Dexamethasone (Dex) and Thalidomide (Thal) in Relapsed Multiple Myeloma Patients (Pts).
A. Badros,Olga Goloubeva,Bashi Ratterree,Sabrina Natt,Aaron P. Rapoport,Javier Bolaños-Meade,Ben Zhang,J. Zeldis,Stanley R. Frankel,Barry Meisenberg,James A. Zwiebel,Jodi A. Flaws,Dragana Tomic,Robert G. Fenton +13 more
TL;DR: G3139 appears to over-come resistance to Dex/Thal with impressive clinical responses in relapsed/refractory MM patients and the G3139, Dex and Thal regimen is well tolerated in relapse MM Pts.